Regeneron Plans To File Cemdisiran For gMG But Will Face Tough Market

siRNA Medicine Will Compete Against FcRN Inhibitors

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.